RESUMEN
We report the case of a 58-year-old man presenting with chest pain who underwent percutaneous coronary intervention (PCI). The patient subsequently developed a fever over 38°C, pain on micturition, and cloudy urine 3 days following PCI. Urine cultures were positive for Escherichia coli and Enterococcus faecalis, whereas blood cultures were negative. Arthritis occurred two weeks following urinary tract infection (UTI). We herein present a rare case of reactive arthritis caused by UTI following PCI.
Asunto(s)
Artritis Reactiva/etiología , Infecciones Urinarias/complicaciones , Enterococcus faecalis , Escherichia coli , Humanos , Masculino , Persona de Mediana Edad , Urinálisis , Infecciones Urinarias/microbiologíaRESUMEN
Myxoma induces the onset of paraneoplastic syndromes by excreting various humoral mediators and is therefore known to present with diverse symptoms. A 40-year-old woman was admitted to our hospital for the treatment of an esophageal ulcer, the cause of which could not be identified on various examinations. Notably, a left atrial tumor was incidentally found on chest enhanced computed tomography. The esophageal ulcer, which was intractable to conventional therapy, improved with the administration of 5-aminosalicylate, a drug known to inhibit IL-1ß. This inhibitory action effectively suppressed the development of myxoma-induced paraneoplastic syndrome.
Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Enfermedades del Esófago/patología , Atrios Cardíacos/patología , Neoplasias Cardíacas/diagnóstico , Mesalamina/administración & dosificación , Mixoma/diagnóstico , Úlcera/patología , Adulto , Enfermedades del Esófago/etiología , Femenino , Neoplasias Cardíacas/inmunología , Neoplasias Cardíacas/patología , Humanos , Hallazgos Incidentales , Mixoma/inmunología , Mixoma/patología , Tomografía Computarizada por Rayos X , Úlcera/etiologíaAsunto(s)
Tronco Braquiocefálico/anomalías , Anomalía Torsional/complicaciones , Estenosis Traqueal/etiología , Malformaciones Vasculares/complicaciones , Anciano de 80 o más Años , Diagnóstico Diferencial , Femenino , Humanos , Índice de Severidad de la Enfermedad , Tomografía Computarizada por Rayos X , Anomalía Torsional/diagnóstico , Estenosis Traqueal/diagnóstico , Malformaciones Vasculares/diagnósticoRESUMEN
A 66-year-old man was admitted due to repeated syncope, and the electrocardiogram showed complete atrioventricular block (CAVB). He had moderate aortic valve stenosis (AS) with a severely calcified valve. This case indicates that if calcification spreads into the cardiac conduction system, it may cause CAVB. Although CAVB is not typically considered a main cause of syncope in AS patients, it should nevertheless be considered in the differential diagnosis.
Asunto(s)
Estenosis de la Válvula Aórtica/complicaciones , Bloqueo Atrioventricular/complicaciones , Calcinosis/complicaciones , Síncope/etiología , Anciano , Humanos , MasculinoRESUMEN
Patients with myxoma normally present with cardiovascular symptoms due to mitral valve obstruction caused by the tumor. However, some cases are difficult to diagnose because the findings of auscultation are normal and there are no cardiovascular symptoms. A 62-year-old man presented at a nearby clinic with a fever. No cardiac murmurs were heard on a physical examination. Abdominal ultrasonography was conducted to evaluate the origin of the fever, and a giant left atrial myxoma was discovered incidentally. Although many myxoma cases are found on transthoracic echocardiography, we herein describe a case of a giant left atrial myxoma incidentally discovered on abdominal ultrasonography.
Asunto(s)
Neoplasias Cardíacas/diagnóstico por imagen , Mixoma/diagnóstico por imagen , Abdomen/diagnóstico por imagen , Fiebre de Origen Desconocido/etiología , Atrios Cardíacos/diagnóstico por imagen , Atrios Cardíacos/cirugía , Neoplasias Cardíacas/complicaciones , Neoplasias Cardíacas/cirugía , Humanos , Hallazgos Incidentales , Masculino , Persona de Mediana Edad , Mixoma/complicaciones , Mixoma/cirugía , UltrasonografíaRESUMEN
Although coagulase-negative staphylococci (CoNS) is a frequent cause of prosthetic valve endocarditis, native valve endocarditis (NVE) caused by CoNS is not commonly seen. Its high mortality is well known; however, there are no systematic reports published in Japan. We herein report the cases of two Japanese patients with CoNS NVE who were admitted to our hospital located in Tokyo and conduct literature searches on CoNS NVE in Japan from 1983 to March 2012 using PubMed and ICHUSHI WEB (Japan Medical Abstract Society). We also summarize the features of 22 Japanese patients with CoNS NVE, including our patients.
Asunto(s)
Pueblo Asiatico , Endocarditis Bacteriana/diagnóstico , Enfermedades de las Válvulas Cardíacas/diagnóstico , Infecciones Estafilocócicas/diagnóstico , Staphylococcus epidermidis/aislamiento & purificación , Anciano , Coagulasa/aislamiento & purificación , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/terapia , Femenino , Enfermedades de las Válvulas Cardíacas/microbiología , Enfermedades de las Válvulas Cardíacas/terapia , Humanos , Persona de Mediana Edad , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/terapia , Staphylococcus epidermidis/enzimologíaRESUMEN
Tolvaptan (TLV), which is an antagonist to the vasopressin V2 receptor, was approved by Japanese authorities for the treatment of "volume overload in heart failure when adequate response is not obtained with other diuretics (e.g. loop diuretics)". An 82-year-old female Japanese patient was admitted to our hospital due to congestive heart failure (CHF) and exacerbation of type 2 chronic respiratory failure, which improved with ventilator support and treatment with furosemide; however, the CHF worsened again due to anemia and undernutrition. TLV (7.5 mg/day) was given. The free-water clearance value showed the efficacy of TLV; it was -0.04 before and 0.39 six hours after TLV administration. The administration of TLV was continued for five consecutive days, and the fractional excretion of sodium showed the efficacy of furosemide; it was 1.7% before and 5.2% five days after TLV administration. It is known that the long-term usage of loop diuretics causes tolerance because it promotes sodium re-absorption through the proximal renal tubules by activating the renin-angiotensin-aldosterone system. A patient with CHF was treated successfully by concomitant administration of TLV with furosemide. TLV worked both directly and indirectly; it promoted free-water filtration as its direct effect and sodium filtration as its indirect effect.
RESUMEN
OBJECTIVE: Red blood cell distribution width (RDW) is a numerical measure of erythrocyte size variation. It has been recently reported to be an independent prognostic marker of heart failure (HF). Previous studies on RDW were mostly designed for middle-aged and elderly patients (60-79 years old), therefore, there is no established limit for super-elderly patients (≥ 80 years old). The purpose of this study was to evaluate RDW as an effective tool to detect fatal HF in super-elderly patients. METHODS: The medical records and death certificates of 160 consecutive patients admitted to the Department of Cardiology in Juntendo Tokyo Koto Geriatric Medical Center and who died from June 2002 to October 2010 were reviewed. The causes of death were reviewed, and the factors, including RDW, that might have been related to the fatal HF were evaluated using multivariate logistic regression analysis. RESULTS: HF was the major cause of death [52 patients (32.5%), 29 females, age 84.0 ± 7.5 years], followed by pneumonia (18.8%, 30/160), and acute myocardial infarction (16.3%, 26/160). The most common cause of HF was atrial fibrillation (36.6%, 19/52), followed by hypertensive heart disease (19.2%, 10/52) and valvular disorders (17.3%, 9/52). The multivariate logistic regression analysis found that a high RDW (≥ 16.5%) was an independent factor related to fatal HF (OR 2.36, 95% CI 1.10, 5.04, p=0.03). CONCLUSION: HF was the major cause of death, and RDW ≥ 6.5 was significantly associated with fatal HF in super-elderly patients.
Asunto(s)
Índices de Eritrocitos/fisiología , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/mortalidad , Anciano , Anciano de 80 o más Años , Causas de Muerte , Eritrocitos/patología , Femenino , Insuficiencia Cardíaca/sangre , Humanos , Modelos Logísticos , Masculino , Valor Predictivo de las Pruebas , Estudios RetrospectivosRESUMEN
Although it is well known that certain characteristics, such as older age, female gender, hypertension, and high body mass index, are closely associated with severe arterial tortuosity among patients undergoing transradial coronary angiography, few data are available regarding useful predictors of severe arterial tortuosity among geriatric patients. The purpose of the present study was to evaluate the characteristics of geriatric patients with severe tortuosity of the right subclavian artery or brachiocephalic artery. The coronary angiographic reports of patients with severe tortuosity of the right subclavian artery or brachiocephalic artery and age- and gender-matched control patients were retrospectively evaluated. A total of 847 consecutive patients underwent right transradial coronary angiography. Of these patients, 48 (5.7%) had severe tortuosity (29 women, age 73.4 ± 8.6 years). The factors associated with severe arterial tortuosity were greater body mass index (odds ratio 1.17, p = 0.02), the presence of a prominently projected aortic arch on a chest radiograph (odds ratio 5.62, p <0.01), and lower serum creatinine value (odds ratio 0.05, p <0.01). In conclusion, the presence of a prominently projected aortic arch on the chest radiograph is a useful predictor of severe arterial tortuosity.
Asunto(s)
Aorta Torácica/diagnóstico por imagen , Tronco Braquiocefálico/diagnóstico por imagen , Angiografía Coronaria , Arteria Subclavia/diagnóstico por imagen , Anomalía Torsional/diagnóstico por imagen , Anciano , Cateterismo Cardíaco , Estudios de Casos y Controles , Creatinina/sangre , Femenino , Humanos , Masculino , Arteria Radial , Estudios Retrospectivos , Índice de Severidad de la EnfermedadRESUMEN
The left internal thoracic artery (LITA) is the conduit of choice for coronary artery bypass (CABG) due to favorable long-term patency. Uncommonly, diffuse narrowing like a string without significant stenosis of an anastomosis is observed in the LITA graft (called "string sign"). Isolated left main trunk (LMT) diseases were reported to regress in some cases. However, the relationship between "string sign" and the regression of solitary LMT disease remains unknown.We retrospectively studied 40 consecutive patients with isolated LMT stenosis who underwent CABG using LITA and who underwent angiography before and after operation (31 males, 9 females, mean age, 65.0 years). The patients were divided into 2 groups according to the postoperative angiographic outcomes of the LITA graft: one group included patients with "string sign" (6 patients), the other group consisted of patients with a patent LITA graft (34 patients).There were no significant differences in clinical backgrounds between the two groups. The 2 groups showed similar quantitative % coronary artery stenosis of the LMT before operation (77.5% versus 76.8%) and the observation period was similar in both groups. Coronary angiography after CABG revealed that % stenosis of the LMT in patients with "string sign" was significantly less than that in patients with a patent LITA graft (41.7 ± 26% versus 82.5 ± 11%, P < 0.001). Regression in LMT was significantly more frequently observed in the "string sign group". Furthermore, ostial stenosis was more frequent in patients with "string sign". "String phenomenon" of the LITA graft is one of the signs related to the regression of LMT stenosis, and especially in ostial stenosis of the LMT.
Asunto(s)
Puente de Arteria Coronaria , Estenosis Coronaria/diagnóstico por imagen , Estenosis Coronaria/cirugía , Arterias Mamarias/trasplante , Anciano , Angiografía Coronaria , Femenino , Humanos , Masculino , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
BACKGROUND: A previous study reported that amlodipine retarded coronary plaque progression in patients with coronary artery disease. The goal of this multicenter study was to determine which calcium-channel blockers (CCBs) other than amlodipine attenuated the progression of plaque volume (PV) accessed by intravascular ultrasound (IVUS). METHODS AND RESULTS: ALPS-J was a prospective, randomized open-label study conducted at 5 centers. Patients who had hypertension and were scheduled for coronary intervention were enrolled. Subjects were randomly assigned to receive 16 mg/day of azelnidipine or 5mg/day of amlodipine administered for 48 weeks. The primary endpoint was the percent change in coronary PV measured by IVUS. Between 2007 and 2009, 199 patients were enrolled; 115 had evaluable IVUS images at both baseline and after 48 weeks of treatment. Blood pressure significantly reduced to 128/68 mmHg at follow-up. The lipid profiles in the 2 groups were comparable (low-density lipoprotein cholesterol: 97 mg/dl). The %change in PV showed a significant regression of 4.67 and 4.85% in the azelnidipine and amlodipine groups, respectively. The upper limit of the 95% confidence interval of the mean difference in %change PV between the 2 groups (0.18%, 95% confidence interval 4.62 to 4.98%) did not exceed the pre-defined non-inferiority margin of 6.525%. CONCLUSIONS: ALPS-J demonstrated that azelnidipine was not inferior to amlodipine for primary efficacy. In addition to standard medical therapy, dihydropyridine CCBs will retard PV progression in hypertensive patients.
Asunto(s)
Amlodipino/administración & dosificación , Ácido Azetidinocarboxílico/análogos & derivados , Enfermedad de la Arteria Coronaria/tratamiento farmacológico , Dihidropiridinas/administración & dosificación , Hipertensión/complicaciones , Amlodipino/uso terapéutico , Ácido Azetidinocarboxílico/administración & dosificación , Ácido Azetidinocarboxílico/uso terapéutico , Presión Sanguínea/efectos de los fármacos , Bloqueadores de los Canales de Calcio , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Dihidropiridinas/uso terapéutico , Humanos , Lípidos/sangre , Placa Aterosclerótica/tratamiento farmacológico , Ultrasonografía IntervencionalRESUMEN
To determine whether the initial degree of coronary narrowing prior to a first myocardial infarction (MI) affects left ventricular function, we analyzed paired coronary angiograms and left ventriculography in 41 consecutive MI patients in whom coronary angiography was obtained before and after MI. Patients were divided into 2 groups according to coronary narrowing of the infarct culprit lesion at first angiogram; a significant narrowing group (group S, 15 patients) and a nonsignificant narrowing group (group N, 26 patients). Significant narrowing was defined as more than 75% stenosis of an infarct-related segment in the first angiography and nonsignificant narrowing was less than 50% narrowing. Clinical characteristics were similar in the two groups, with the exception of initial diameter stenosis. LV function was normal in both groups at initial examination. Group S patients had a higher prevalence of angina prior to MI (73% versus 23%; P = 0.001), good collateral development (73% versus 35%; P = 0.02), and non-Q MI (73% versus 27%; P = 0.004) than group N patients. RWM was also superior in group S compared with group N. The deterioration of global and infarction zone function was mild in group S compared with group N (group S; median EF -10%, RWM -0.27 SD/chord, group N; median EF -26%, RWM -1.62 SD/chord, P = 0.001). We conclude that deterioration of LV wall motion in patients with severe stenosis in their initial stenosis would be milder than in AMI that developed from a mild degree of stenosis.
Asunto(s)
Estenosis Coronaria/patología , Estenosis Coronaria/fisiopatología , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Función Ventricular Izquierda/fisiología , Estudios de Cohortes , Circulación Colateral , Angiografía Coronaria , Estenosis Coronaria/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/etiología , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Volumen Sistólico/fisiologíaRESUMEN
PURPOSE: Many trials have shown that calcium channel blockers (CCBs) can reduce the cardiovascular (CV) events in patients with coronary artery disease (CAD). The mechanisms of this effect could be associated with plaque regression due to the anti-atherosclerotic properties of CCBs. The goal of this study is to determine the effects of CCB on volumetric quantitative changes of coronary plaques accessed by intravascular ultrasound (IVUS). To confirm this hypothesis, a multicenter randomized trial of CCBs treatment with azelnidipine or amlodipine will be conducted in hypertensive CAD patients undergoing elective percutaneous coronary intervention (PCI). METHODS AND RESULTS: Patients who have hypertension and are scheduled for PCI will be enrolled. Subjects will be randomized to azelnidipine or amlodipine and observed for 48 weeks. The primary endpoint will be the percent change of coronary plaque volume. The secondary endpoint will include inflammatory markers, antioxidant activity, and incidence of composite cardiovascular events. CONCLUSIONS: In this study, we will investigate the improvement of coronary plaque with IVUS by treatment with two dihydropyridine CCBs in hypertensive patients undergoing elective PCI. This result will lead to the discovery of more effective drug therapy for inhibition of coronary events.
Asunto(s)
Amlodipino/uso terapéutico , Ácido Azetidinocarboxílico/análogos & derivados , Bloqueadores de los Canales de Calcio/uso terapéutico , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/prevención & control , Dihidropiridinas/uso terapéutico , Hipertensión/complicaciones , Hipertensión/tratamiento farmacológico , Adulto , Anciano , Amlodipino/efectos adversos , Ácido Azetidinocarboxílico/efectos adversos , Ácido Azetidinocarboxílico/uso terapéutico , Bloqueadores de los Canales de Calcio/efectos adversos , Enfermedad de la Arteria Coronaria/complicaciones , Dihidropiridinas/efectos adversos , Progresión de la Enfermedad , Método Doble Ciego , Determinación de Punto Final , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ultrasonografía , Adulto JovenRESUMEN
UNLABELLED: Lipoprotein (a) (Lp(a)) is an independent risk factor for myocardial infarction (MI). It may also inhibit the fibrinolysis system, and Lp (a) affects the natural course of MI and the results of thrombolytic therapy. The purpose of this study was to investigate the influence of Lp (a) on the residual lesion stenosis of the infarction-related arteries (residual stenosis) in acute MI patients in whom reperfusion therapy was not performed. We studied 129 MI patients not given reperfusion therapy who underwent coronary angiography in the chronic stage. Morning fasting blood was collected and Lp (a), blood sugar, total cholesterol (TC), triglycerides (TG), and hemoglobin A1c (HbA1c) were measured. Residual stenosis was compared between the low Lp(a) group (< 30 mg/dL) and the high Lp(a) group (> or = 30 mg/dL). It was severe in the high Lp(a) group (85.0 +/- 24.9% vs 94.5 +/- 15.5%, P = 0.0044). We also compared residual stenosis and TIMI classification between younger and older, non-DM and DM, non-HT and HT, low-TC (< 220 mg/dL) and high-TC (> or = 220 mg/dL), low-TG (< 150 mg/dL) and high-TG (> or = 150 mg/dL), and low-Lp (a) and high-Lp (a) patients. Only the serum Lp (a) level affected the residual stenosis and TIMI classification (P < 0.05). CONCLUSION: These findings suggest that elevated Lp (a) levels inhibit fibrinolysis.
Asunto(s)
Estenosis Coronaria/sangre , Lipoproteína(a)/sangre , Infarto del Miocardio/sangre , Anciano , Angiografía Coronaria , Estenosis Coronaria/diagnóstico por imagen , Vasos Coronarios/patología , Complicaciones de la Diabetes , Diabetes Mellitus/sangre , Femenino , Fibrinólisis , Humanos , Lípidos/sangre , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/patología , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores SexualesRESUMEN
Coronary artery calcification (CAC) was assessed by cinefluoroscopy and its extent was scored (CAC score) in 2,163 consecutive patients undergoing coronary angiography, based on the angiographic and clinical data, the patients were categorized into 8 types of coronary artery disease (CAD). The CAC score was lowest in angiographically normal subjects (0.12+/-0.60) and highest in patients with silent myocardial ischemia (14.31+/-8.61). Risk factors for CAC were advanced age, male sex (at age <80 years), hypertension, diabetes mellitus, and a high grade of organic coronary stenosis. The CAC score in patients with acute coronary syndrome (unstable angina+acute myocardial infarction; 5.48+/-7.42) was significantly lower than that in those with chronic CAD (silent ischemia+stable angina; 9.72+/-8.73; p<0.0001), but was still higher than that in normal subjects or those with vasospastic angina (0.92+/-2.88; p<0.0001). The results indicate that CAC is a manifestation of coronary atherosclerosis and its appearance depends on the pathological type of ischemic heart disease. Fixed stenosis with a slow and chronic process tends to be associated with CAC. The clinical implication of extensive CAC in acute coronary syndrome compared with normal subjects should be further investigated.
Asunto(s)
Angina Inestable/complicaciones , Calcinosis/complicaciones , Vasos Coronarios , Infarto del Miocardio/complicaciones , Distribución por Edad , Anciano , Arterias , Calcinosis/diagnóstico por imagen , Calcinosis/epidemiología , Cinerradiografía , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad Coronaria/complicaciones , Femenino , Humanos , Incidencia , Japón/epidemiología , Masculino , Persona de Mediana Edad , Isquemia Miocárdica/complicaciones , Isquemia Miocárdica/diagnóstico por imagen , Valores de Referencia , Factores de Riesgo , Distribución por Sexo , SíndromeRESUMEN
Idiopathic bilateral atrial dilatation (IBAD) is an extremely rare anomaly and is usually associated with atrial fibrillation. Plasma levels of atrial natriuretic peptide (ANP) have been shown to increase in patients with atrial fibrillation. However, secretion of ANP and brain natriuretic peptide (BNP) in patients with IBAD remains unclear. We investigated the clinical features of 9 patients with IBAD and 16 age- and sex-matched patients with lone atrial fibrillation (LAF). Plasma levels of ANP and BNP were measured, and echocardiographic parameters were followed. Left (LAV) and right atrial volumes (RAV) were significantly higher in patients with IBAD than in patients with LAF (both p < 0.01). There were no differences between patients with IBAD and LAF in other echocardiographic parameters. The percent increases in LAV and RAV in patients with IBAD exceeded those in patients with LAF (both p < 0.01). Plasma levels of BNP and the BNP/ANP ratios in patients with IBAD were significantly higher than those in patients with LAF (both p < 0.01), but there was no significant difference in plasma levels of ANP. Regarding the clinical course of the patients with IBAD compared with those with LAF, the atrial volume increased gradually, and plasma levels of BNP were significantly higher. These findings suggested that IBAD was not only influenced by long-term atrial fibrillation, but also by subclinical left ventricular dysfunction.